BACKGROUND: A previous study at the GHESKIO HIV clinic confirmed that highly active antiretroviral therapy (HAART) prophylaxis reduced mother-to-child transmission (MTCT) and infant mortality in Haiti. This analysis looks at maternal outcomes in this cohort after delivery. METHODS: Records of 508 HIV-positive Haitian women who delivered between 1999 and 2005 were analyzed. We examined mortality, loss to follow-up, time to death or HAART initiation, and time of decline of CD4 count to 350 cells/μL. RESULTS: One hundred seventy women reached a CD4 ≤200 or developed clinical AIDS and were started on long-term HAART. The median CD4 count at HAART initiation was 178 (interquartile range, 106-227). CD4 decline was stratified by CD4 at delivery to project the mean months to a CD4 of 350. With an initial CD4 of 350-499 cells/μL, it was 19 months (95% confidence interval: 14 to 28) while with a CD4 >500 cells/μL, it was 71 months (95% confidence interval: 59 to 88). At study close, 257 women remained in follow-up, with loss to follow-up 3 times less in those on HAART (3.2/100 person-years) than those not on HAART (9.8/100 person-years). CONCLUSIONS: The threshold for starting treatment was often missed in HIV-infected women after delivery. Success of follow-up of women after delivery was favorably influenced by being on HAART. Women with high (>500) initial CD4 counts had a protracted time (5-7 years) before they reach a threshold CD4 count, in contrast to those with CD4 <500 cells/μL. Strategies for postpartum treatment of women should be informed by the speed with which they are likely to progress.
BACKGROUND: A previous study at the GHESKIO HIV clinic confirmed that highly active antiretroviral therapy (HAART) prophylaxis reduced mother-to-child transmission (MTCT) and infant mortality in Haiti. This analysis looks at maternal outcomes in this cohort after delivery. METHODS: Records of 508 HIV-positive Haitian women who delivered between 1999 and 2005 were analyzed. We examined mortality, loss to follow-up, time to death or HAART initiation, and time of decline of CD4 count to 350 cells/μL. RESULTS: One hundred seventy women reached a CD4 ≤200 or developed clinical AIDS and were started on long-term HAART. The median CD4 count at HAART initiation was 178 (interquartile range, 106-227). CD4 decline was stratified by CD4 at delivery to project the mean months to a CD4 of 350. With an initial CD4 of 350-499 cells/μL, it was 19 months (95% confidence interval: 14 to 28) while with a CD4 >500 cells/μL, it was 71 months (95% confidence interval: 59 to 88). At study close, 257 women remained in follow-up, with loss to follow-up 3 times less in those on HAART (3.2/100 person-years) than those not on HAART (9.8/100 person-years). CONCLUSIONS: The threshold for starting treatment was often missed in HIV-infectedwomen after delivery. Success of follow-up of women after delivery was favorably influenced by being on HAART. Women with high (>500) initial CD4 counts had a protracted time (5-7 years) before they reach a threshold CD4 count, in contrast to those with CD4 <500 cells/μL. Strategies for postpartum treatment of women should be informed by the speed with which they are likely to progress.
Authors: Bruce A Larson; Alana Brennan; Lynne McNamara; Lawrence Long; Sydney Rosen; Ian Sanne; Matthew P Fox Journal: Bull World Health Organ Date: 2010-04-16 Impact factor: 9.408
Authors: Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall Journal: Lancet Date: 2010-07-16 Impact factor: 79.321
Authors: Katharina Kranzer; Jennifer Zeinecker; Philip Ginsberg; Catherine Orrell; Nosindiso N Kalawe; Stephen D Lawn; Linda-Gail Bekker; Robin Wood Journal: PLoS One Date: 2010-11-02 Impact factor: 3.240
Authors: Marie-Marcelle Deschamps; Francine Noel; Jerry Bonhomme; Jessy G Dévieux; Gilbert Saint-Jean; Yuwei Zhu; Peter Wright; Jean W Pape; Robert M Malow Journal: Rev Panam Salud Publica Date: 2009-01
Authors: Cécile Alexandra Peltier; Gilles François Ndayisaba; Philippe Lepage; Johan van Griensven; Valériane Leroy; Christine Omes Pharm; Patrick Cyaga Ndimubanzi; Olivier Courteille; Vic Arendt Journal: AIDS Date: 2009-11-27 Impact factor: 4.177
Authors: Francine Noel; Sapna Mehta; Yuwei Zhu; Patricia De Matteis Rouzier; Abdias Marcelin; Jian R Shi; Claudine Nolte; Linda Severe; Marie Marcelle Deschamps; Daniel W Fitzgerald; Warren D Johnson; Peter F Wright; Jean W Pape Journal: PLoS One Date: 2008-11-14 Impact factor: 3.240
Authors: Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole Journal: Lancet Date: 2009-04-08 Impact factor: 79.321
Authors: Risa M Hoffman; Konstantia Nadia Angelidou; Sean S Brummel; Friday Saidi; Avy Violari; Dingase Dula; Vidya Mave; Lee Fairlie; Gerhard Theron; Moreen Kamateeka; Tsungai Chipato; Benjamin H Chi; Lynda Stranix-Chibanda; Teacler Nematadzira; Dhayendre Moodley; Debika Bhattacharya; Amita Gupta; Anne Coletti; James A McIntyre; Karin L Klingman; Nahida Chakhtoura; David E Shapiro; Mary Glenn Fowler; Judith S Currier Journal: HIV Clin Trials Date: 2018-12
Authors: Sheree R Schwartz; Newton Kumwenda; Johnstone Kumwenda; Shu Chen; Lynne M Mofenson; Allan W Taylor; Mary Glenn Fowler; Taha E Taha Journal: Matern Child Health J Date: 2016-03
Authors: Christopher J Colvin; Sarah Konopka; John C Chalker; Edna Jonas; Jennifer Albertini; Anouk Amzel; Karen Fogg Journal: PLoS One Date: 2014-10-10 Impact factor: 3.240
Authors: Heather Bailey; Ruslan Malyuta; Igor Semenenko; Claire L Townsend; Mario Cortina-Borja; Claire Thorne Journal: Reprod Health Date: 2016-03-22 Impact factor: 3.223
Authors: Jodie Dionne-Odom; Courtney Massaro; Kristen M Jogerst; Zhongze Li; Marie-Marcelle Deschamps; Cleonas Junior Destine; Redouin Senecharles; Moleine Moles Aristhene; Joseph Yves Domercant; Vanessa Rouzier; Peter F Wright Journal: AIDS Res Treat Date: 2016-08-29
Authors: Deanna P Jannat-Khah; Michelle Unterbrink; Margaret McNairy; Samuel Pierre; Dan W Fitzgerald; Jean Pape; Arthur Evans Journal: BMC Public Health Date: 2018-11-19 Impact factor: 3.295